Is there a pathogenic link between gamma heavy chain disease and chronic arthritis?

Current Opinion in Rheumatology

Volumn 12, Issue 1, 2000, Pages 65-70

  Husby, Gunnar ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ARTHRITIS; BONE MARROW; CHRONIC DISEASE; DISEASE ASSOCIATION; HEAVY CHAIN DISEASE; HUMAN; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNOVIUM;

ADULT; ARTHRITIS; CHRONIC DISEASE; FEMALE; HEAVY CHAIN DISEASE; HUMANS;

EID: 0033987994     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200001000-00011     Document Type: Review

References (37)

1. 1 Mapp P, Stevens CR, Blake DR: The physiology of the joint and its disturbance in inflammation. In Oxford Textbook of Rheumatology, 2nd edn. Maddison PJ, Isenberg DA, Woo P, Glass DN, eds. Oxford University Press, 1998:441-454.
2. 2 Duff GW: Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol 1994, 23 (suppl 100):9-19.
3. 3 Edwards J: Rheumatoid arthritis and autoimmunity: Causes and possible cure? 1998. Available at http://www.ucl.ac.uk/@7Eregfjxe/. Accessed June 11, 1999. How B cells producing pathogenic antibodies may survive and even proliferate in the synovial tissue to cause chronic, erosive arthropathy.
4. 4 Arend WP: The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum 1997, 40:595-597.
5. 5 Firestein GS, Zvaifler NJ: Anticytokine therapy in rheumatoid arthritis. N Engl J Med 1997, 337:195-197.
6. 6 Gallo GR, Lazowski P, Kumar A, Vidal R, Baldwin DS, Buxbaum JN: Renal and cardiac manifestations of B-cell dyscrasias with nonamyloidotic monoclonal light chain and light and heavy chain deposition diseases. Adv Nephrol 1998, 28:355-382.
7. 7 Dhodapkar MV, Merlini G, Solomon A: Biology and therapy of immunoglobulin deposition diseases. Hematol Oncol Clin North Am, 1997, 11:89-110.
8. 8 Husby G: Amyloidosis. In Oxford Textbook of Rheumatology, 2nd edn. Maddison PJ, Isenberg DA, Woo P, Glass DN, eds. Oxford University Press, 1998:1433-1444. An overview of the chemical, pathogenic and clinical aspects of amyloidosis, including immunoglobulin-related amyloidosis.
9. 9 Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogne M, Chauffert B, et al.: Heavy-chain deposition disease. N Engl J Med 1993, 329:1389-1393.
10. 10 Khamlichi AA, Aucoutiroer P, Preud'Homme JL, Cogne M: Structure of abnormal heavy chains in human heavy-chain-deposition disease. Eur J Biochem 1995, 229:54-60.
11. 11 Fermand JP, Brouet JC, Danon F, Seligmann M: Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine 1989, 68:321-335.
12. 12 Franklin EC, Mowenstein J, Bigelow B, Melzer M: Heavy chain disease: a new disorder of serum gammaglobulins. Report of the first case. Am J Med 1964, 37:332-350.
13. 13 Galanti LM, Doyen C, Van der Maelen C, Daparé N, Bosly A, Pouthier F, et al: Biological diagnosis of a gamma-1-heavy chain disease in an asymptomatic patient. Eur J Haematol 1995, 54:202-204.
14. 15 Goossens T, Klein U, Küppers: Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA 1998, 95:2463-2468. Hypermutation gives rise to the heavy chain deletions consistently seen in HCD.
15. 16 Husby G, Blichfeldt P, Brinch L, Brandtzaeg P, Mellbye OJ, Sletten K, Stenstad T: Chronic arthritis and γ heavy chain disease. Coincidence or pathogenic link? Scand J Rheumatol 1998, 27:257-264. The original report on the patient with articular γ HCDD discussed above.
16. 17 Eulitz M, Weiis DT, Solomon A: Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci USA 1990, 87:6542-6546.
17. 18 Rott T, Vizjak A, Lindic, Hvala A, Perkovic, Cernelc: IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant, 1998, 13:1825-1828. Reviews the literature on the organ distribution of γHCD.
18. 19 Larsen A, Dale K, Eek M: Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diag 1977, 18:481-491.
19. 20 Husby G: Amyloidosis. Semin Arthritis Rheum 1992, 22:67-82.
20. 21 Vitali C, Baglioni Ȧ, Vivaldi I, Cacialli R, Tavoni A, Bombardieri S: Erosive arthritis in monoclonal gammopathy of uncertain significanse: report of four cases. Arthritis Rheum 1991, 34:1600-1615.
21. 22 Munthe E, Natvig JB: Complement-fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells. Scand J Immunol 1972, 1:217-229.
22. 23 Mellbye OJ, Vartdal F, Pahle J, Mollnes TE: IgG and IgA subclass distribution of total immunoglobulin and rheumatoid factors in rheumatoid tissue plasma cells. Scand J Rheumatol 1990, 19:333-340.
23. 24 Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB: Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol 1995, 44:394-399.
24. 25 Michaelsen TE, Garred Ȧ, Aase A: Human IgG subclasses induce complement-mediated cytolysis differently upon changes in antibody affinity, complement concentration, antigen concentration and epitope density. Eur J Immunol 1991, 21:11-16.
25. 26 Lust JA: Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin Proc 1994, 69:691-697.
26. 27 Waage A, Espevik T, Kaufmann C, Husby G: Interleukin 6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989, 50:394-398.
27. 28 Bataille R, Harousseau JL: Multiple myeloma. N Engl J Med 1997, 336:1657-1664.
28. 29 Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L et al: Human interleukin-17. A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999, 42:963-970. This report, in addition to references 30 and 31, suggests IL-17 may be an initiating cytokine leading to proinflammatory and hematopoietic cytokine production and stimulation of osteoclastogenesis.
29. 30 Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin J-J, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Golstein P, Banchereau J, Lebecques S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoetic cytokines. J Exp Med 1996, 183:2593-2603.
30. 31 Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishivama S, Saito S, Inoue K, Kamatani N: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1998, 103:1345-1352.
31. 32 Müller-Ladner U, Kriegsmann J, Gay RE, Gay S: Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995, 21:675-690.
32. 33 Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y, et al.: C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate fas expression in rheumatoid synoviocytes. Arthritis Rheum 1999, 42:954-962.
33. 34 Moskovitz T, Jacobsen DR, Buxbaum JN: N-ras oncogene activation in a patient with γ heavy chain disease. Am J Hematol 1992, 41:302-303.
34. 35 Van de Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang PP, Kamel OW: Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum 1996, 39:638-642. Links Epstein-Barr virus to lymphoproliferative disease and RA.
35. 36 Albani S, Carson DA, Roudier J: Genetic and environmental factors in the immunopathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 1992, 18:729-740.
36. 37 Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W: Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999, 353:550-553. Apparently successful use of autologous stem cell transplantation in chronic arthritis.
37. 38 Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'Hara C, Arkin CF, Wright DG, Skinner M: Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood 1998, 91:3662-3670.